Los Angeles Capital Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-68,324
| Closed | -$237K | – | 1230 |
|
|
2023
Q3 | $237K | Buy |
68,324
+11,800
| +21% | +$40.9K | ﹤0.01% | 1028 |
|
|
2023
Q2 | $263K | Buy |
56,524
+10,670
| +23% | +$49.6K | ﹤0.01% | 1044 |
|
|
2023
Q1 | $212K | Sell |
45,854
-17,270
| -27% | -$79.8K | ﹤0.01% | 1115 |
|
|
2022
Q4 | $510K | Sell |
63,124
-5,560
| -8% | -$44.9K | ﹤0.01% | 897 |
|
|
2022
Q3 | $381K | Hold |
68,684
| – | – | ﹤0.01% | 1001 |
|
|
2022
Q2 | $358K | Buy |
68,684
+27,680
| +68% | +$144K | ﹤0.01% | 1093 |
|
|
2022
Q1 | $337K | Hold |
41,004
| – | – | ﹤0.01% | 1191 |
|
|
2021
Q4 | $610K | Hold |
41,004
| – | – | ﹤0.01% | 911 |
|
|
2021
Q3 | $775K | Sell |
41,004
-2,750
| -6% | -$52K | ﹤0.01% | 863 |
|
|
2021
Q2 | $813K | Buy |
+43,754
| New | +$813K | ﹤0.01% | 943 |
|
|
2020
Q4 | – | Sell |
-29,641
| Closed | -$298K | – | 1548 |
|
|
2020
Q3 | $298K | Buy |
29,641
+5,787
| +24% | +$58.2K | ﹤0.01% | 1272 |
|
|
2020
Q2 | $185K | Buy |
+23,854
| New | +$185K | ﹤0.01% | 1406 |
|